Lacticin 481 Synthetase as a General Serine/Threonine
Kinase by You, Young
Ok et al.
Lacticin 481 Synthetase as a General Serine/
Threonine Kinase
Young Ok You
†, Matthew R. Levengood
‡, L.A. Furgerson Ihnken
‡, Aaron K. Knowlton
†, and
Wilfred A. van der Donk
†,‡,*
†Department of Biochemistry and
‡Department of Chemistry and Howard Hughes Medical Institute, University of Illinois at
UrbanaChampaign, 600 South Mathews Avenue, Urbana, Illinois 61801
P
osttranslational modiﬁcations (PTMs) greatly in-
creasethefunctionalandstructuralspaceacces-
sible to genome-encoded proteins and are a
key mechanism to control dynamic cellular processes,
mostly via phosphorylation, glycosylation, and histone
modiﬁcation (1). Synthetic peptides carrying deﬁned
modiﬁcations have played important roles in a large
numberofstudies,fromuseassubstratesinenzymeas-
says to identiﬁcation of proteinprotein interactions.
In addition, both global and selective methods have
been developed for modiﬁcation of preformed synthetic
peptides (2−7). More recently, synthetic peptides have
also found use in the construction of full length proteins
carrying PTMs using orthogonal ligation techniques
(8−11). Despite the great utility of these synthetic func-
tionalized peptides, their synthesis has limitations for
routine use in nonspecialist laboratories. Methods that
introduce posttranslational modiﬁcations in a general,
mild, and non-sequence-speciﬁc manner using biologi-
cally produced peptides are complementary and in
somecasesconceptuallypreferableastheycantakead-
vantage of rapid and inexpensive access to libraries
and methods to screen them. Unfortunately, most en-
zymes that introduce posttranslational modiﬁcations
are highly selective. Here we describe a facile enzymatic
method to produce peptides containing phosphory-
lated serine residues by taking advantage of the sub-
strate promiscuity of lacticin 481 synthetase (LctM). In
addition, the methodology is shown to be amenable for
the preparation of glycopeptides and peptides contain-
ing analogs of acetylated and methylated lysines found
in histones.
LctM converts a linear ribosomally synthesized pep-
tide (LctA) into a polycyclic structure characteristic for
the class of lantibiotic antimicrobial peptides (12). The
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ABSTRACT Methods that introduce posttranslational modiﬁcations in a gen-
eral, mild, and non-sequence-speciﬁc manner using biologically produced pep-
tides have great utility for investigation of the functions of these modiﬁcations. In
this study, the substrate promiscuity of a lantibiotic synthetase was exploited for
the preparation of phosphopeptides, glycopeptides, and peptides containing
analogs of methylated or acetylated lysine residues. Peptides attached to the
C-terminus of the leader peptide of the lacticin 481 precursor peptide were phos-
phorylated on serine residues in a wide variety of sequence contexts by the R399M
and T405A mutants of lacticin 481 synthetase (LctM). Serine residues located as
many as 30 amino acids C-terminal to the leader peptide were phosphorylated.
Wild-type LctM was shown to dehydrate these peptides to generate dehydro-
alanine-containing products that can be conveniently modiﬁed with external nu-
cleophiles including thiosaccharides, 2-(dimethylamino)ethanethiol, and N-acetyl
cysteamine, resulting in mimics of O-linked glycopeptides and acetylated and
methylated lysines.
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the C-terminal part of its substrate (the structural pep-
tide)tothecorrespondingdehydroalanine(Dha)andde-
hydrobutyrine (Dhb) residues, respectively (Figure 1,
panel a) (13). The polycyclic structures are formed by
subsequent reaction of cysteine thiols with the dehy-
dro amino acids in a Michael-type addition. The
N-terminal leader peptide is not modiﬁed in this pro-
cess but is important for efﬁcient modiﬁcation of the
structural peptide (14). Previous studies have demon-
strated high substrate promiscuity for LctM, which can
dehydratearangeofnonlantibioticpeptidesattachedto
the leader peptide (15−17). The mechanism of dehydra-
tion involves phosphorylation of the serine/threonine
targeted for dehydration and subsequent elimination of
the phosphate group (Figure 1, panel a) (18, 19).
A comprehensive site-directed mutagenesis study of
LctM identiﬁed two residues that when mutated did not
affect the phosphorylation step but compromised the
elimination step (19). Hence, these mutant enzymes,
LctM-R399M and LctM-T405A, were envisioned to be
potentially useful as kinases that could phosphorylate
peptides of interest attached to the C-terminus of the
leader peptide of LctA. The current study demonstrates
the potential of this methodology.
RESULTS AND DISCUSSION
To explore the substrate speciﬁcity for phosphoryla-
tion, a library of plasmids was generated with oligonu-
cleotides encoding nonapeptides with random se-
quences inserted in frame behind an lctA gene fragment
encoding the leader peptide. All nonapeptides I were
designed to contain a serine at position 5 (Figure 1,
panel b). In order to provide the possibility to render
the leader peptide traceless, a Factor Xa protease cleav-
age site was engineered N-terminal to the random pep-
tide sequence. After transformation of Escherichia coli
cells with the vector library, colonies were picked, and
their plasmids were sequenced. On the basis of the di-
versitywithintheirsequences,asubsetwaschosenthat
contained a variety of different residues ﬂanking the
serine (hydrophobic, hydrophilic, cationic, anionic, and
cyclic). These peptides were heterologously expressed
Figure 1. LctM-catalyzed dehydration and phosphorylation. a) Posttranslational modiﬁcation of the LctA peptide by the en-
zyme LctM to generate dehydroamino acids. Dehydration involves a two-step sequence of phosphorylation and elimina-
tion. b) Design of the substrate peptides to investigate the scope of peptide phosphorylation. The recognition sequence
for Factor Xa protease is indicated in blue. All peptides have a His6-tag at their N-terminus originating from the pET15b
plasmid with the following sequence: GSSHHHHHHSSGLVPRGSH.
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(Table 1).
Incubation of the puriﬁed peptides with LctM-T405A
or LctM-R399M, MgCl2, and ATP resulted in clean con-
version to phosphorylated peptides as determined by
MALDI-TOF mass spectrometric analysis. As a represen-
tativeexample,Figure2,paneladepictstheLctM-T405A
catalyzed phosphorylation of a peptide containing
RWVRSALLI behind the Factor Xa cleavage site (entry 1,
Table 1; for all other entries spectral data is provided in
Supporting Information). The T405A mutant enzyme dis-
played activity higher than that of LctM-R399M and
was used for further study. For peptides that were good
substrates, phosphorylation on a 24 nmol scale was
complete within1ha sdetermined by HPLC (see Sup-
porting Information) resulting in yields in the 80% range
afterpuriﬁcation.Forcomparison,asubsetofthesepep-
tides was tested for dehydration by wild-type (wt) LctM,
resulting in complete dehydration within 30 min
(Table 1). As expected on the basis of the known activ-
ity of lantibiotic synthetases (12, 15, 20−22), LctM-
T405A also phosphorylates threonine residues as
shown in entry 2, Table 1. Similarly, incubation of pep-
tide II (Figure 1, panel b) with LctM-T405A resulted in a
monophosphorylated peptide in 30 min with the phos-
phate located on the threonine residue. The peptide in
entry 2 was also phosphorylated on a larger scale (2.5
mg) resulting in full conversion as determined by HPLC.
After HPLC puriﬁcation, 1.2 mg of isolated phosphory-
lated peptide was obtained.
The remarkable promiscuity of LctM-T405A is illus-
tratedbythewidevarietyofresiduesﬂankingserinethat
are tolerated, which include hydrophobic, hydrophilic,
acidic, basic, and aromatic residues (Table 1). Flanking
Gly residues have been reported to reduce serine/threo-
nine dehydration activity by LctM (15), and the same
was observed for phosphorylation by LctM-T405A in this
study. Phosphorylation was also sluggish for serine resi-
dues ﬂanked by two proline, two negatively charged
residues,orcombinationsthereof(datanotshown);one
of these residues ﬂanking a serine did not deactivate
phosphorylation (e.g., entries 46, Table 1). A single
ﬂanking proline residue also did not prevent phosphory-
lation activity (entries 7, 13, and 14); this is an impor-
TABLE 1. Results of incubation of LctM-T405A with peptide sequences attached to the
leader peptide of LctA as depicted in Figure 1, panel b
Entry Sequence No. of phosphorylations Reaction time Time for full dehydration by wt LctM
1 RWVRSALLI 1 30 min 30 min
2 RLIKTFAYV 1 1 h 30 min
3 RLIKSFAYV 1 30 min 30 min
4 GHAGSAPPA 1 3 h
5 RLLRSDLVP 1 2 h
6 RPDESLNRL 1 2 h 30 min
7 LAYPSLRLL 1 30 min 30 min
8 ILILSVPVA 1 30 min 30 min
9 FAFYSCPVH 1 30 min
10 LCLCSALLC 1 30 min
11 CYCVSQGPA 1 30 min 30 min
12 LRRASVA 1 1 h 30 min
13 LASPLVNSHV 2 4 h
14 HPSPARPSDA 1 6 h
15 PLSLPALSRA 2 1 h 30 min
16 ARSLGAQSVL 2 4 h 30 min
17 RLIKSFAYVRLLRSLDVP 2 1 h 30 min
18 RLIKSFAYVHAIKSLRNRGRQLSKIPA 3 4 h
19 RLIKSFAYVRLLRSLDVPVARISHNKA 3 4 h
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motif is phosphorylated in many regulatory pathways by
cyclin-dependent kinases (23) and mitogen-activated
protein(MAP)kinases(24).Theutilityofthemethodisil-
lustrated in entry 12, in which a previously reported po-
tent inhibitor of human tripeptidyl peptidase II (25) was
readily prepared.
Next, a series of decapeptides III (Figure 1, panel b)
containing two serine residues located at positions 3
and 8 was investigated (e.g., entries 1316, Table 1).
LctM-T405A phosphorylated these peptides twice
(Figure 2, panel b), simultaneously demonstrating the
ability to generate bisphosphorylated peptides and that
phosphorylation is not dependent on the position of
the serine. This methodology is complementary to solid
phase peptide synthesis of phosphopeptides using
monobenzyl protected Fmoc-pSer (26, 27) and may be
particularly useful for longer peptides that are more dif-
ﬁculttopreparesynthetically.Totesttheapplicabilityto-
ward longer peptides, the length of the sequences ap-
pended to the LctA leader was increased to 18 and 27
residues (entries 1719, Table 1). These peptides con-
tain two or three serine residues at positions 5 and 14
or 5, 14, and 23. LctM-T405A efﬁciently phosphorylated
these peptides twice (for the peptide in entry 17,
Figure 2, panel c) and three times (entries 18 and 19),
demonstratingthatlongerpeptidesareamenabletothis
methodology. In the latter two peptides, phosphoryla-
tion occurs on a serine located 30 residues C-terminal
to the end of the leader peptide. Similarly, in vivo stud-
ies on lantibiotic dehydratases have shown that these
enzymescandehydrateserine/threonineresiduesasfar
as 42 residues C-terminal from the leader peptide in
non-natural designed peptides (22). After phosphoryla-
tion by LctM-T405A, the leader peptide could be conve-
niently cleaved with Factor Xa, as shown for representa-
tive examples in Figure 2, panels df. The convergent
nature and mild conditions of the methodology as well
as its use with bacterially expressed peptides bodes
well for its potential application toward the preparation
of peptide libraries, possibly in combination with phage
display technology.
In addition to its utility to prepare phosphopeptides
in a leader-peptide-dependent manner, the use of LctM
Figure 2. Representative examples of LctM-T405A catalyzed phosphorylation of peptides attached to the LctA leader se-
quence. MALDI-TOF mass spectra of the substrates are shown in dashed lines and assay products in solid lines. All entries
refer to Table 1: a) entry 1; b) entry 15; c) entry 17. Panels df show the products after treatment with Factor Xa: d) en-
try 17; e) entry 18; f) entry 19. Factor Xa also cleaves after Arg16 in the His6-tag resulting in the LctA leader peptide with a
GSH tripeptide at its N-terminus. This peptide is indicated with an asterisk in panels e and f.
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vestigated. Ribosomally synthesized peptides do not
contain reactive electrophilic groups. Therefore, the abil-
ity to introduce dehydroalanines in a mild and efﬁcient
manner into a range of peptides with wild-type LctM pro-
vides opportunities to derivatize
these reactive handles chemoselec-
tively. We (28−30) and others (31,
32) have shown that dehydroala-
nines can be used to decorate pep-
tides and proteins with prenyl groups
and thiosaccharides as well as with
thialysine in various methylation
states. In these previous studies,
Dha was introduced using chemical
methods. We show here that these
structures can be readily introduced
using enzymatic methods. As antici-
pated, treatment of the peptides
listed in Table 1 with wild-type LctM,
ATP, and Mg2 resulted in the efﬁ-
cient conversion of serine and threo-
nine residues to the corresponding
Dha and Dhb. As shown in Table 2,
subsequent addition of 1-thio glu-
cose nucleophile to the Dha-
containing peptides provided thia-
analogs of O-linked glycopeptides.
We have shown previously that this
methodology can also be used with
more elaborate synthetic thiosaccha-
rides including tumor-associated an-
tigens (30). Michael-type additions with N-acetyl cys-
teamine or 2-(dimethylamino)ethane thiol resulted in
thia-analogs of methylated or acetylated lysines. Such
methylated thialysines have been shown to be fully
functional in histone H3 (33). The high conversion ob-
TABLE 2. Enzymatic installation of dehydroamino acids
and subsequent derivatization to S-linked glycopep-
tides, N-dimethyllysine, and N-acetyllysine analogs
Figure 3. Representative examples of the transformation of
dehydropeptides with various nucleophiles. MALDI-MS
data for a) dehydropeptide substrate, b) product contain-
ing N-dimethylthialysine (entry 1, Table 2), c) product
containing N-acetylthialysine (entry 2, Table 2), and
d) product containing -1-thioglucose (entry 3, Table 2).
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for some representative examples in Figure 3 (for other
examples see Supporting Information). An inherent po-
tential disadvantage of the use of Michael-type addi-
tions for conjugation is the possible generation of ste-
reoisomers at the -carbon of the former dehydro amino
acids. Whether this possibility presents a true limita-
tion requires further investigation. Certainly, in many
cases non-native linkages produced from various liga-
tion methods have not prevented their successful use.
Importantly, for the only case examined thus far,
Michael ligation with N-acetyl cysteamine to generate
an acetylated thiaLys in histone H3 resulted in a pro-
tein product that was a substrate for HDAC3 (32).
Whether the ligation was stereoselective in the context
of the H3 protein or whether HDAC3 has deacetylation
activity for H3 containing D-N-acetyl thiaLys was not
investigated.
In summary, we present methodology that allows
rapid, mild, and convergent access to peptides contain-
ing serine phosphorylations, methylations and acetyla-
tions of lysine analogs, and S-linked glycosylations. The
methodology is complementary to solid-phase peptide
synthesis(SPPS)andmaybeparticularlysuitedforlabo-
ratories that are not experts in SPPS. Genes encoding
for the precursor peptides can be conveniently intro-
ducedintoplasmidsthatalreadycontaintheoligonucle-
otide sequence encoding the LctA leader peptide, which
canberenderedtracelessaftercleavagewithacommer-
cial protease.
METHODS
Cloning, Expression, and Puriﬁcation of Peptides. All materials
and molecular biology methods used to generate the expres-
sion constructs for the substrate peptides are described in Sup-
porting Information. Conditions used for expression of the pep-
tides in E. coli and subsequent puriﬁcation by nickel afﬁnity
chromatography followed by HPLC are also described in Sup-
porting Information as is the protocol to purify LctM and LctM-
T405A.
Phosphorylation of Serine-Containing Peptides by LctM-T405A
o na2 4 nmol Scale. HPLC-puriﬁed peptides (2040 M) were
reacted with LctM-T405A or LctM-R399 M (2 M ﬁnal concentra-
tion) at 25 °C in 100 L of buffer containing 50 mM Tris·HCl,
pH 7.5, 1 mM ATP, and 10 mM MgCl2. Reactions were stopped
at the times indicated in Table 1 by adding 5% TFA to give a ﬁ-
nal concentration of 0.5%. Phosphorylated peptides were puri-
ﬁed by HPLC as described in Supporting Information. For MS
analysis before puriﬁcation, assay products were desalted us-
ing C18 ZipTips (Millipore) and eluted with 4 Lo f-cyano-4-
hydroxy cinnamic acid. From this solution, 3 L was applied to
the MALDI target and analyzed for phosphorylation by MALDI-
TOF MS.
Phosphorylation on a 0.38 mol Scale. The peptide in entry 2
of Table 1 (2.5 mg) was divided over three eppendorf tubes,
and to each tube was added 1 mL of 50 mM MOPS (pH 7.5) con-
taining 10 mM MgCl2, 5 mM ATP, and 5 mM TCEP providing a
peptide concentration of 120 M. To two of the tubes was
added His6-LctM-T405A (2 M ﬁnal concentration), and to the
third tube was added His6-LctM-R399 M (ﬁnal concentration
2 M). The three tubes were incubated at 25 °C for 12 h and
analyzed by HPLC, which showed that all substrate had been
consumed for each reaction. The phosphopeptides were puri-
ﬁed by analytical RP-HPLC with a Vydac C4 column (0.46 cm 
25 cm) using a linear gradient of 20% to 100% solvent B over
35 min (solvent A  0.1% TFA in H2O; solvent B  80% MeCN,
20% H2O, 0.086% TFA). The fractions containing phosphopep-
tide as determined by MALDI-TOF mass spectrometry were com-
bined and lyophilized, giving 1.2 mg of a white powder (48%).
General Conjugation Protocol. Peptides (2040 M) were in-
cubated under identical conditions as described above for phos-
phorylation except that His6LctM was added instead of a mu-
tant enzyme. After 30 min of incubation, the products were
puriﬁed by HPLC (Supporting Information), and to puriﬁed dehy-
drated peptide (1 L, 1 g) were added 5 L of 50 mM phos-
phate buffer at pH 8.0 and thiol (either dissolved in the same
buffer or added neat, in the case of N-acetyl cysteamine). The re-
actions were incubated for 12 h at 25 °C and then puriﬁed
by Zip-tip for MALDI-TOF MS analysis. As shown in Supplemen-
tary Figure S3, an excess of just 5 equiv of thiol resulted in ex-
cellent conversion.
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